Skip to content

Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients

The Influence of Electrical Acupoint Stimulation at Different Frequencies on Hemodynamics During Anesthesia Induction in Patients Undergoing TAVR Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07365345
Acronym
FRESH-T
Enrollment
150
Registered
2026-01-26
Start date
2026-01-30
Completion date
2026-12-31
Last updated
2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia Induction, Electro-acupuncture, Hemodynamic Stability, Transcatheter Aortic Valve Replacement (TAVR)

Brief summary

Within 30 minutes before anesthesia, acupoint electrical stimulation at different frequencies were applied at Neiguan, Jian Shi, and Baihui. The changes in blood pressure during the anesthesia induction period were compared between the high-frequency group and the low-frequency group.

Interventions

Electrical stimulation are administered at Neiguan, Jian Shi, and Baihui. The stimulation starts at 15 minutes before anesthesia induction and ends at 15 minutes after anesthesia induction.

Sponsors

Air Force Military Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The age of the patients is 60 years or older; * Patients who are scheduled to undergo TAVR surgery under general anesthesia;

Exclusion criteria

* Body mass index less than 18 kg/m2 or greater than 30 kg/m2; * Hemodynamic instability (severe arrhythmia, decompensated heart failure); * Hypotension after admission requiring intervention with vasoactive drugs; * Severe liver or kidney dysfunction; * Those who are contraindicated for electrical stimulation, including those with local skin damage, infection, or having implanted electrophysiological devices in the body.

Design outcomes

Primary

MeasureTime frameDescription
The area under the curve representing the change in mean arterial pressure during the induction period relative to the baseline.from start of induction to 15 minutes after inductionThe MAP is continuously recorded by the DoCare Information System every 30 seconds. The AUC below baseline MAP is calculated as: ∑ (((Si - Sbaseline)+(Si-1 - Sbaseline))/2 × ΔX), where Sbaseline is the baseline MAP, Si is the MAP at minute i (i = 0.5, 1, 1.5, …, 15) after start of anesthesia induction, and ΔX is the time interval between measurements.

Secondary

MeasureTime frameDescription
Incidence of hypotension during the induction periodfrom start of induction to 15 minutes after induction
The dosage of vasoactive drugsfrom start of induction to 15 minutes after induction
The incidence of major complications (cardiovascular adverse events, acute kidney injury, delirium)from end of surgery to discharge from the hospital, at an average of 5 days
Length of hospital stayfrom end of surgery to discharge from the hospital, at an average of 5 days
The rate of patients admitted to the intensive care unit (ICU) after surgeryfrom end of surgery to discharge from the hospital, at an average of 5 days
The rate of patients achieving the best recovery after surgery (discharged within 5 days after surgery, without major complications, no incision infection, no readmission, and survive within 30 days after surgery)from end of surgery to 30 days after surgery
The score of the discharge quality assessment scaleat discharge from the hospital, at an average of 5 days after surgeryQuality of Recovery, QoR-15 15 items across 5 dimensions: physical comfort, physical independence, psychological support, emotional state, and pain. Each item is scored from 0 to 10. The total score ranges from 0 to 150, with a higher score representing better recovery. A change of 8 points or more is considered a Minimally Clinically Important Difference (MCID), meaning a meaningful improvement or decline from the patient's perspective.

Countries

China

Contacts

CONTACTZhihong Lu
deerlu23@163.com86-13891975018
CONTACTHailong Dong
hldong6@hotmail.com86-29-84775337

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026